Robeco Institutional Asset Management
KYNB

Robeco Institutional Asset Management’s Kyntra Bio KYNB Stock Holding History

Robeco Institutional Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-541
Closed -$253K – 1068
2023
Q1 		$253K Buy
+541
New +$286K ﹤0.01% 920

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robeco Institutional Asset Management's KYNB Position: Q2 2023 in Review

Robeco Institutional Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 541 shares — an estimated $253K sold.

Robeco Institutional Asset Management first reported a position in KYNB in Q1 2023 and held it in 1 quarter. The position peaked at $253K in Q1 2023. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Robeco Institutional Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 541 Kyntra Bio shares in Q2 2023, an estimated $253K.
  • Robeco Institutional Asset Management first reported a position in Kyntra Bio in Q1 2023 and held it in 1 quarter.
  • Robeco Institutional Asset Management's Kyntra Bio position peaked at $253K in Q1 2023.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2023, filed 24 Jul 2023.